Sertoli-Leydig cell tumors (SLCTs), constitute less than 0.5% of all ovarian tumors. SLCT are rare after menopause (less than10%), 75 years, unmarried, postmenopausal since 30 years, presented with complaints of abdominal swelling. On examination, abdominal mass of 36 weeks, hard, immobile felt. Ultrasonography of abdomen showed lobulated solid cystic lesion of size 22 x 15 x 27 cms with bilateral ovaries not separately visualized. Moderate free fluid in the abdomen, suggestive of malignant neoplastic etiology. CECT Abdomen + pelvis suggestive of primary ovarian malignancy with omental deposits and pelvic adenopathy. CA 125-415.1 Patient underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy with huge tumour mass excision (weight 5.25 kg) with umbilical hernia repair. Frozen section suggestive of a huge mass of 30 x 20 x 15 cm, multilobulated, yellowish white tan in colour, solid-cystic in consistency, seen arising from right ovary. Omentum appears normal. Histopathology report s/o-Moderately differentiated Sertoli Leydig cell tumor. Reporting the first, this huge, in this age group with atypical presentation.
INTRODUCTION
Ovarian sex cord-stromal tumors are uncommon neoplasms, constitute less than 0.5% of all ovarian tumors and typically present in the first two to three decades of life, with the exception of adult granulosa cell tumors, which typically present later, with risk for development peaking at age 50 to 55 years. 1 In aggregate, these tumors account for approximately 5% of ovarian malignancies in women age 15 to 24 years. These tumors are unilateral, confined to the ovary, and large frequently characterized by the presence of androgen production, only 30% of patients display virilization or defeminisation on presentation. 2 Sex cord-stromal tumors usually present with the typical symptoms of an adnexal mass, including abdominal pain, distention, and, rarely, torsion.
CASE REPORT
A 75 years old female, unmarried, postmenopausal since 30 years, recently diagnosed case of hypertension, presented with complaints of abdominal swelling gradually increasing in size over a period of one year. On general examination patient was moderately built, vitally stable, per abdomen distended, dilated veins present, umbilical hernia of size 5 x 5 cm present, mass of 36 weeks, hard, immobile, lower limit not palpable, per speculum/per vaginum examination not done in vivo of unmarried status. On investigating further, haemoglobin was 9.5% g. Ultrasonography of abdomen showed uterus 6.5 x 10 x 9.5 cms, appears mildly bulky, a well-defined hypoechoic lesion 4.2 x 4.4 cms in size in uterine body suggestive of intramural fibroid, a large well defined, lobulated solid cystic lesion of size 22 x 15 x 27 cms noted involving whole of the abdomen extending from epigastrium to hypogastrium region, also extending into the pelvis with bilateral ovaries not separately visualized from the lesion (right > left). The solid areas show vascularity within on colour doppler. The lesion is also extending through a defect in midline in umbilical region 4 cm in size. Moderate free fluid in the abdomen. No significant lymphadenopathy suggestive of malignant neoplastic etiology. CECT (abdomen and pelvis) showed a large well defined, lobulated solid cystic lesion of size 17 x 20 x 28 cms noted involving whole of the abdomen extending from supramesocolic peritoneum inferiorly up to the POD. Bilateral ovaries not separately visualized from the lesion (right > left) ( Figure 1-6 ). The lesion is also extending through a defect in midline in umbilical region 4 cm in size. Anteriorly fat planes with the urinary bladder are indistinct, posteriorly fat planes with the rectum and uterus are lost. Diffuse omental nodularity is seen. Mild ascites is seen. Bilateral sub-centimeter sized external and internal iliac lymph nodes are seen suggestive of primary ovarian malignancy with omental deposits and pelvic adenopathy CA 125-415.1. 
Frozen section report
Right ovarian tumour 31 x 22 x 15 cm in size, externally lobulated with stretched out right fallopian tube 21 cm in length, on cut sections tumour is solid and cystic with 70% solid areas, soft to firm, yellowish tan in colour, 30% tumour is cystic, cyst wall is smooth, one cyst shows papillary projections s/o right ovarian mass -benign sex cord stromal tumour suggestive of Sertoli cell tumour. 
Final histopathology report
Microscopic description -sections through right ovarian mass reveal tumour arranged in compact bundles and fascicles with oedematous stroma, at places lobular architecture is seen. Within the cellular area comprised of spindle cells with bland oval to elongated nuclei with eosinophilic cytoplasm. Few cysts are lined with flattened Sertoli cells. Few areas show round cells with eosinophilic, vacuolated cytoplasm with eccentrically placed nuclei, areas of hyalinization. Mitotic activity seen (Figure 11-13 ).
Impression Figure 14 shows right ovarian mass -sex cord stromal tumour with differentials as- 
DISCUSSION
A case has been reported of Sertoli-Leydig cell tumor of the ovary in a postmenopausal woman, usually, the patients affected by this tumor were young women with virilization signs. Patient doesn't show any virilization or other signs which indicates the presence of this tumor. SLCTs are commonly unilateral and usually confined to the ovary at the time of diagnosis. Bilateral involvement is seen in less than 2% of the cases. Grossly, they are predominantly solid but cystic areas may be seen. Welldifferentiated SLCTs are smaller in size with a mean diameter of 5 cm while intermediate and poorly differentiated tumours have an average diameter of 15 cm. Ultrasound is regarded as a useful imaging technique for the initial assessment of SLCTs. Other imaging techniques like CT, MRI, and PET scans are more useful in tumour staging.
The histologic appearance of these tumours is extremely variable and has been categorized into the following groups-
• Well differentiated -solid or hollow tubules composed of Sertoli cells surrounded by a fibrous stroma containing clusters of Leydig cells. Lacks significant atypia or mitotic activity. Patient had tumour confined to the ovary and was treated surgically with total abdominal hysterectomy with bilateral salpingo-oophorectomy. Prognosis of SLCTs is generally good due to the fact that 80% of them are in stage IA of FIGO, fully encapsulated, and moderately differentiated and depends on the stage and degree of differentiation of tumours. Poor differentiation, presence of heterologous elements, high mitotic counts and rupture of tumour are associated with increased risk of metastasis. Adjuvant chemotherapy is recommended for patients with advanced stage, intermediate and poor differentiation, retiform pattern, and presence of heterologous elements. 4
CONCLUSION
To conclude, SLCTs are rare ovarian tumours belonging to the group of sex cord stromal tumours. Absence of endocrine manifestations, presentation in postmenopausal age group (Less than 10% of patients are reportedly older than age 50), and this big size of the tumor, were the unusual features observed in this case.
